Lattice Biologics Ltd LBLTF

Comparing Lattice Biologics and Capricor

[gainwidpatience]

LBL sp $0.085
Capricor sp US$7.05

- Their Product is quite similar.
- Capricor only treated 6 patients under 'compassionate care'. Why can't LBL ask FDA for trying their product on patients under 'compassionate care'?
https://finance.yahoo.com/news/capricor-data-reports-100-percent-131510422.html

- Capricor didn't even do placebo study..whereas LBL had stated in their previous NR that they are doing investigation and placebo study.

- If LBL can't get trials in US hospitals, why can't they try other counties to prove their product is working? I know that one of the Montana website reported that they are doing studies 3 places worldwide.

- None of the studies related to MSC/stem cells are failed on Covid-19. It will be a big surprise if their Amnio Boost product don't work.

What do you guyz think about success of Capricor vs current state of LBL.

[Nomoreshells4me]

one thing I've noticed with Capricor , Mesoblast and Pluristem is the minuscule amount of shares outstanding. The turning point for LBL will be a news release that concludes phase 1 study with a positive outcome and states that the FDA approved the findings and fast tracked Amnioboost to phase 2. I know I'm asking a lot but if this happens then we're pi$$ing in the tall grass with the

[schrodingerscat]

they have paperwork, CAP-1002 has jumped through the basic hoops, Amnioboost has yet to be tested on healthy people to see if it makes them unhealthy.

[Boobah]

This post has been removed in accordance with Community Policy